Roles for transforming growth factor beta superfamily proteins in early folliculogenesis

Seminars in Reproductive Medicine

Volumn 27, Issue 1, 2009, Pages 14-23

  Trombly, Daniel J ^a,c   Woodruff, Teresa K ^a,b,c   Mayo, Kelly E ^a,c  

^a Center for Reproductive Science   (United States)

^b Department of Obstetrics   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Activin; Folliculogenesis; Growth factors; Primordial follicle; Tgf superfamily

Indexed keywords

ACTIVIN; BONE MORPHOGENETIC PROTEIN; FOLLISTATIN; GROWTH DIFFERENTIATION FACTOR 9; INHIBIN; MUELLERIAN INHIBITING FACTOR; TRANSFORMING GROWTH FACTOR BETA;

CELL PROLIFERATION; GRANULOSA CELL; NONHUMAN; OVARY FOLLICLE; OVARY FOLLICLE DEVELOPMENT; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW;

ANIMALS; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; FEMALE; GROWTH DIFFERENTIATION FACTOR 9; HUMANS; MODELS, BIOLOGICAL; MULTIGENE FAMILY; OVARIAN FOLLICLE; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 61549108607     PISSN: 15268004     EISSN: 15264564     Source Type: Journal    
DOI: 10.1055/s-0028-1108006     Document Type: Review

References (100)

1. Molyneaux KA, Stallock J, Schaible K, Wylie C. Time-lapse analysis of living mouse germ cell migration. Dev Biol 2001;240(2):488-498
2. Pepling ME, Spradling AC. Female mouse germ cells form synchronously dividing cysts. Development 1998;125(17):3323-3328
3. Pepling ME, Spradling AC. Mouse ovarian germ cell cysts undergo programmed breakdown to form primordial follicles. Dev Biol 2001;234(2):339-351
4. Van Wagenen G, Simpson ME. Embryology of the ovary and testis: Homo sapiens and Macaca mulatta. New Haven, CT: Yale University Press; 1965
5. McGee EA, Hsueh AJ. Initial and cyclic recruitment of ovarian follicles. Endocr Rev 2000;21(2):200-214
6. Baker SJ, Spears N. The role of intra-ovarian interactions in the regulation of follicle dominance. Hum Reprod Update 1999;5(2):153-165
7. Barnett KR, Schilling C, Greenfeld CR, Tomic D, Flaws JA. Ovarian follicle development and transgenic mouse models. Hum Reprod Update 2006;12(5):537-555
8. Richards JS. Perspective: the ovarian follicle - a perspective in 2001. Endocrinology 2001;142(6):2184-2193
9. Epifano O, Dean J. Genetic control of early folliculogenesis in mice. Trends Endocrinol Metab 2002;13(4):169-173
10. Pepling ME. From primordial germ cell to primordial follicle: mammalian female germ cell development. Genesis 2006;44(12):622-632
11. Nilsson EE, Detzel C, Skinner MK. Platelet-derived growth factor modulates the primordial to primary follicle transition. Reproduction 2006;131(6):1007-1015
12. Skinner MK. Regulation of primordial follicle assembly and development. Hum Reprod Update 2005;11(5):461-471
13. Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003;113(6):685-700
14. Pangas SA, Matzuk MM. Genetic models for transforming growth factor beta superfamily signaling in ovarian follicle development. Mol Cell Endocrinol 2004;225(1-2):83-91
15. Massague J. TGF-beta signal transduction. Annu Rev Biochem 1998;67:753-791
16. Shimasaki S, Moore RK, Otsuka F, Erickson GF. The bone morphogenetic protein system in mammalian reproduction. Endocr Rev 2004;25(1):72-101
17. Kaivo-Oja N, Jeffery LA, Ritvos O, Mottershead DG. Smad signalling in the ovary. Reprod Biol Endocrinol 2006;4:21
18. Balemans W, Van Hul W. Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators. Dev Biol 2002;250(2):231-250
19. Lutz M, Knaus P. Integration of the TGF-beta pathway into the cellular signalling network. Cell Signal 2002;14(12):977-988
20. Juengel JL, McNatty KP. The role of proteins of the transforming growth factor-beta superfamily in the intra-ovarian regulation of follicular development. Hum Reprod Update 2005;11(2):143-160
21. Kulkarni AB, Huh CG, Becker D, et al. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 1993;90(2):770-774
22. Ingman WV, Robker RL, Woittiez K, Robertson SA. Null mutation in transforming growth factor beta1 disrupts ovarian function and causes oocyte incompetence and early embryo arrest. Endocrinology 2006;147(2):835-845
23. Muttukrishna S, Tannetta D, Groome N, Sargent I. Activin and follistatin in female reproduction. Mol Cell Endocrinol 2004;225(1-2):45-56
24. Woodruff TK, D'Agostino J, Schwartz NB, Mayo KE. Dynamic changes in inhibin messenger RNAs in rat ovarian follicles duringthe reproductive cycle. Science 1988;239(4845):1296-1299
25. Carroll RS, Corrigan AZ, Gharib SD, Vale W, Chin WW. Inhibin, activin, and follistatin: regulation of folliclestimulating hormone messenger ribonucleic acid levels. Mol Endocrinol 1989;3(12):1969-1976
26. Woodruff TK, Krummen LA, Lyon RJ, Stocks DL, Mather JP. Recombinant human inhibin A and recombinant human activin A regulate pituitary and ovarian function in the adult female rat. Endocrinology 1993;132(6):2332-2341
27. Lewis KA, Gray PC, Blount AL, et al. Betaglycan binds inhibin and can mediate functional antagonism of activin signalling. Nature 2000;404(6776):411- 414
28. McMullen ML, Cho BN, Yates CJ, Mayo KE. Gonadal pathologies in transgenic mice expressing the rat inhibin alpha-subunit. Endocrinology 2001;142(11):5005-5014
29. Nakamura T, Takio K, Eto Y, et al. Activin-binding protein from rat ovary is follistatin. Science 1990;247(4944):836-838
30. Findlay JK. An update on the roles of inhibin, activin, and follistatin as local regulators of folliculogenesis. Biol Reprod 1993;48(1):15-23
31. Nahum R, Thong KJ, Hillier SG. Metabolic regulation of androgen production by human thecal cells in vitro. Hum Reprod 1995;10(1):75-81
32. Bristol-Gould SK, Kreeger PK, Selkirk CG, et al. Postnatal regulation of germ cells by activin: the establishment of the initial follicle pool. Dev Biol 2006;298(1):132-148
33. Martins da Silva SJ, Bayne RA, Cambray N, et al. Expression of activin subunits and receptors in the developing human ovary: activin A promotes germ cell survival and proliferation before primordial follicle formation. Dev Biol 2004;266(2):334-345
34. Weng Q, Wang H, Medan S, et al. Expression of inhibin/activin subunits in the ovaries of fetal and neonatal mice. J Reprod Dev 2006;52(5):607-616
35. Matzuk MM, Finegold MJ, Mather JP, et al. Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice. Proc Natl Acad Sci USA 1994;91(19):8817-8821
36. Kipp JL, Kilen SM, Bristol-Gould S, Woodruff TK, Mayo KE. Neonatal exposure to estrogens suppresses activin expression and signaling in the mouse ovary. Endocrinology 2007;148(5):1968-1976
37. Iguchi T, Fukazawa Y, Uesugi Y, Takasugi N. Polyovular follicles in mouse ovaries exposed neonatally to diethylstilbestrol in vivo and in vitro. Biol Reprod 1990;43(3):478-484
38. Iguchi T, Takasugi N, Bern HA, Mills KT. Frequent occurrence of polyovular follicles in ovaries of mice exposed neonatally to diethylstilbestrol. Teratology 1986;34(1):29-35
39. Jefferson W, Newbold R, Padilla-Banks E, Pepling M. Neonatal genistein treatment alters ovarian differentiation in the mouse: inhibition of oocyte nest breakdown and increased oocyte survival. Biol Reprod 2006;74(1):161-168
40. Jefferson WN, Couse JF, Padilla-Banks E, Korach KS, Newbold RR. Neonatal exposure to genistein induces estrogen receptor (ER)alpha expression and multioocyte follicles in the maturing mouse ovary: evidence for ERbeta-mediated and nonestrogenic actions. Biol Reprod 2002;67(4):1285-1296
41. Chen Y, Jefferson WN, Newbold RR, Padilla-Banks E, Pepling ME. Estradiol, progesterone, and genistein inhibit oocyte nest breakdown and primordial follicle assembly in the neonatal mouse ovary in vitro and in vivo. Endocrinology 2007;148(8):3580-3590
42. Kezele P, Skinner MK. Regulation of ovarian primordial follicle assembly and development by estrogen and progesterone: endocrine model of follicle assembly. Endocrinology 2003;144(8):3329-3337
43. Albrecht ED, Pepe GJ. Endocrinology of pregnancy. In: Brans YW, Kuehl TJ, eds. Non-Human Primates in Perinatal Research. New York, NY: John Wiley and Sons;1988:13-78
44. Zachos NC, Billiar RB, Albrecht ED, Pepe GJ. Developmental regulation of baboon fetal ovarian maturation by estrogen. Biol Reprod 2002;67(4):1148-1156
45. Billiar RB, Zachos NC, Burch MG, Albrecht ED, Pepe GJ. Up-regulation of alpha-inhibin expression in the fetal ovary of estrogen-suppressed baboons is associated with impaired fetal ovarian folliculogenesis. Biol Reprod 2003;68(6):1989-1996
46. Bristol-Gould SK, Hutten CG, Sturgis C, et al. The development of a mouse model of ovarian endosalpingiosis. Endocrinology 2005;146(12):5228-5236
47. Pangas SA, Jorgez CJ, Tran M, et al. Intraovarian activins are required for female fertility. Mol Endocrinol 2007;21(10):2458-2471
48. Jamin SP, Arango NA, Mishina Y, Hanks MC, Behringer RR. Requirement of Bmprla for müllerian duct regression during male sexual development. Nat Genet 2002;32(3):408-410
49. Jorgez CJ, Klysik M, Jamin SP, Behringer RR, Matzuk MM. Granulosa cell-specific inactivation of follistatin causes female fertility defects. Mol Endocrinol 2004;18(4):953-967
50. Drummond AE, Le MT, Ethier JF, Dyson M, Findlay JK. Expression and localization of activin receptors, Smads, and beta glycan to the postnatal rat ovary. Endocrinology 2002;143(4):1423-1433
51. Patsch C, Edenhofer F. Conditional mutagenesis by cell- permeable proteins: potential, limitations and prospects. Handb Exp Pharmacol 2007;178:203-232
52. Li R, Phillips DM, Mather JP. Activin promotes ovarian follicle development in vitro. Endocrinology 1995;136(3):849-856
53. Liu X, Andoh K, Abe Y, et al. A comparative study on transforming growth factor-beta and activin A for preantral follicles from adult, immature, and diethylstilbestrol-primed immature mice. Endocrinology 1999;140(6):2480-2485
54. Yokota H, Yamada K, Liu X, et al. Paradoxical action of activin A on folliculogenesis in immature and adult mice. Endocrinology 1997;138(11):4572- 4576
55. Guo Q, Kumar TR, Woodruff T, et al. Overexpression of mouse follistatin causes reproductive defects in transgenic mice. Mol Endocrinol 1998;12(1):96-106
56. Schmidt D, Ovitt CE, Anlag K, et al. The murine winged- helix transcription factor Foxl2 is required for granulosa cell differentiation and ovary maintenance. Development 2004;131(4):933-942
57. Mizunuma H, Liu X, Andoh K, et al. Activin from secondary follicles causes small preantral follicles to remain dormant at the resting stage. Endocrinology 1999;140(1):37-42
58. Fortune JE, Cushman RA, Wahl CM, Kito S. The primordial to primary follicle transition. Mol Cell Endocrinol 2000;163(1-2):53-60
59. Munsterberg A, Lovell-Badge R. Expression of the mouse anti-müllerian hormone gene suggests a role in both male and female sexual differentiation. Development 1991;113(2):613-624
60. Durlinger AL, Gruijters MJ, Kramer P, et al. Anti-müllerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology 2002;143(3):1076-1084
61. Hirobe S, He WW, Lee MM, Donahoe PK. Müllerian inhibiting substance messenger ribonucleic acid expression in granulosa and Sertoli cells coincides with their mitotic activity. Endocrinology 1992;131(2):854-862
62. Weenen C, Laven JS, Von Bergh AR, et al. Anti-müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol
63. Hum Reprod 2004;10(2):77-83
64. Baarends WM, Uilenbroek JT, Kramer P, et al. Anti-müllerian hormone and anti-müllerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth. Endocrinology 1995;136(11):4951-4962
65. Shimasaki S, Zachow RJ, Li D, et al. A functional bone morphogenetic protein system in the ovary. Proc Natl Acad Sci U S A 1999;96(13):7282-7287
66. Behringer RR, Finegold MJ, Cate RL. Müllerian-inhibiting substance function during mammalian sexual development. Cell 1994;79(3):415-425
67. Durlinger AL, Kramer P, Karels B, et al. Control of primordial follicle recruitment by anti-müllerian hormone in the mouse ovary. Endocrinology 1999;140(12):5789-5796
68. Carlsson IB, Scott JE, Visser JA, et al. Anti-müllerian hormone inhibits initiation of growth of human primordial ovarian follicles in vitro. Hum Reprod 2006;21(9):2223-2227
69. Schmidt KL, Kryger-Baggesen N, Byskov AG, Andersen CY. Anti-müllerian hormone initiates growth of human primordial follicles in vitro. Mol Cell Endocrinol 2005;234(1-2):87-93
70. Behringer RR, Cate RL, Froelick GJ, Palmiter RD, Brinster RL. Abnormal sexual development in transgenic mice chronically expressing müllerian inhibiting substance. Nature 1990;345(6271):167-170
71. Lyet L, Louis F, Forest MG, et al. Ontogeny of reproductive abnormalities induced by deregulation of anti-müllerian hormone expression in transgenic mice. Biol Reprod 1995;52(2):444-454
72. Mishina Y, Whitworth DJ, Racine C, Behringer RR. High specificity of müllerian-inhibiting substance signaling in vivo. Endocrinology 1999;140(5):2084-2088
73. Visser JA, Themmen AP. Anti-müllerian hormone and folliculogenesis. Mol Cell Endocrinol 2005;234(1-2):81-86
74. de Vet A, Laven JS, de Jong FH, Themmen AP, Fauser BC. Antimüllerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril 2002;77(2):357-362
75. Nilsson E, Rogers N, Skinner MK. Actions of anti-müllerian hormone on the ovarian transcriptome to inhibit primordial to primary follicle transition. Reproduction 2007;134(2):209-221
76. Nilsson EE, Skinner MK. Bone morphogenetic protein-4 acts as an ovarian follicle survival factor and promotes primordial follicle development. Biol Reprod 2003;69(4):1265-1272
77. Lee WS, Otsuka F, Moore RK, Shimasaki S. Effect of bone morphogenetic protein-7 on folliculogenesis and ovulation in the rat. Biol Reprod 2001;65(4):994-999
78. Lee WS, Yoon SJ, Yoon TK, et al. Effects of bone morphogenetic protein-7 (BMP-7) on primordial follicular growth in the mouse ovary. Mol Reprod Dev 2004;69(2):159-163
79. Elvin JA, Clark AT, Wang P, Wolfman NM, Matzuk MM. Paracrine actions of growth differentiation factor-9 in the mammalian ovary. Mol Endocrinol 1999;13(6):1035-1048
80. McGrath SA, Esquela AF, Lee SJ. Oocyte-specific expression of growth/differentiation factor-9. Mol Endocrinol 1995;9(1):131-136
81. Aaltonen J, Laitinen MP, Vuojolainen K, et al. Human growth differentiation factor 9 (GDF-9) and its novel homolog GDF-9B are expressed in oocytes during early folliculogenesis. J Clin Endocrinol Metab 1999;84(8):2744-2750
82. Jaatinen R, Laitinen MP, Vuojolainen K, et al. Localization of growth differentiation factor-9 (GDF-9) mRNA and protein in rat ovaries and cDNA cloning of rat GDF-9 and its novel homolog GDF-9B. Mol Cell Endocrinol 1999;156(1-2):189-193
83. Dong J, Albertini DF, Nishimori K, et al. Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature 1996;383(6600):531- 535
84. Nilsson EE, Skinner MK. Growth and differentiation factor-9 stimulates progression of early primary but not primordial rat ovarian follicle development. Biol Reprod 2002;67(3):1018-1024
85. Vitt UA, McGee EA, Hayashi M, Hsueh AJ. In vivo treatment with GDF-9 stimulates primordial and primary follicle progression and theca cell marker CYP17 in ovaries of immature rats. Endocrinology 2000;141(10):3814-3820
86. Hreinsson JG, Scott JE, Rasmussen C, et al. Growth differentiation factor-9 promotes the growth, development, and survival of human ovarian follicles in organ culture. J Clin Endocrinol Metab 2002;87(1):316-321
87. Elvin JA, Yan C, Wang P, Nishimori K, Matzuk MM. Molecular characterization of the follicle defects in the growth differentiation factor 9-deficient ovary. Mol Endocrinol 1999;13(6):1018-1034
88. McNatty KP, Juengel JL, Reader KL, et al. Bone morphogenetic protein 15 and growth differentiation factor 9 co-operate to regulate granulosa cell function. Reproduction 2005;129(4):473-480
89. Spicer LJ, Aad PY, Allen DT, et al. Growth differentiation factor 9 (GDF9) stimulates proliferation and inhibits steroidogenesis by bovine theca cells: influence of follicle size on responses to GDF9. Biol Reprod 2008;78(2):243-253
90. Wu X, Chen L, Brown CA, Yan C, Matzuk MM. Interrelationship of growth differentiation factor 9 and inhibin in early folliculogenesis and ovarian tumorigenesis in mice. Mol Endocrinol 2004;18(6):1509-1519
91. Wang J, Roy SK. Growth differentiation factor-9 and stem cell factor promote primordial follicle formation in the hamster: modulation by follicle-stimulating hormone. Biol Reprod 2004;70(3):577-585
92. Wang C, Roy SK. Expression of growth differentiation factor 9 in the oocytes is essential for the development of primordial follicles in the hamster ovary. Endocrinology 2006;147(4):1725-1734
93. Dube JL, Wang P, Elvin J, et al. The bone morphogenetic protein 15 gene is X-linked and expressed in oocytes. Mol Endocrinol 1998;12(12):1809-1817
94. YanC,WangP,DeMayoJ,etal.Synergisticrolesofbone morphogenetic protein 15 and growth differentiation factor 9 in ovarian function. Mol Endocrinol 2001;15(6):854-866
95. Galloway SM, McNatty KP, Cambridge LM, et al. Mutations in an oocyte-derived growth factor gene (BMP15) cause increased ovulation rate and infertility in a dosage-sensitive manner. Nat Genet 2000;25(3):279-283
96. Otsuka F, Yao Z, Lee T, et al. Bone morphogenetic protein-15. Identification of target cells and biological functions. J Biol Chem 2000;275(50):39523-39528
97. McNatty KP, Juengel JL, Reader KL, et al. Bone morphogenetic protein 15 and growth differentiation factor 9 co-operate to regulate granulosa cell function in ruminants. Reproduction 2005;129(4):481-487
98. Dole G, Nilsson E, Skinner MK. Glial-derived neurotrophic factor promotes ovarian primordial follicle development and cell-cell interactions during folliculogenesis. Reproduction 2008;135(5):671-682
99. Javelaud D, Mauviel A. Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-beta: implications for carcinogenesis. Oncogene 2005;24(37):5742-5750
100. Wiater E, Vale W. Inhibin is an antagonist of bone morphogenetic protein signaling. J Biol Chem 2003;278(10):7934-7941